Search Orphan Drug Designations and Approvals
-
Generic Name: | Allogeneic gene edited BCMA-directed CAR T cells |
---|---|
Date Designated: | 12/18/2019 |
Orphan Designation: | Treatment of multiple myeloma |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 11/21/2022 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Precision BioSciences, Inc. 302 East Pettigrew Street Suite A-100 Durham, North Carolina 27701 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-